文献速递腹部技术与安全CTMR

对比增强CT、双层光谱探测器CT与Gd-EOB-DTPA增强MR检测神经内分泌肿瘤肝转移的头对头比较

Head-to-head comparison of contrast-enhanced CT, dual-layer spectral-detector CT, and Gd-EOB-DTPA-enhanced MR in detecting neuroendocrine tumor liver metastases.
PubMed 文献 · Eur J Radiol · 2024-08-29

回顾性纳入72例疑似神经内分泌肿瘤肝转移患者,比较PEI、DLCT(VMI40keV)与Gd-EOB-DTPA增强MR的诊断效能;共477个病灶(396转移瘤、81良性),MR的AUC 0.97和敏感度0.95最高,DLCT敏感度0.86优于PEI的0.76,差异集中于<10mm病灶。

要点

  • VMI40keV的SNR和CNR在动脉期和静脉期均显著高于PEI(均P<0.01)。
  • 病灶水平AUC:PEI 0.86、DLCT 0.91、Gd-EOB-DTPA增强MR 0.97。
  • 敏感度:PEI 0.76、DLCT 0.86、Gd-EOB-DTPA增强MR 0.95;MR显著高于DLCT和PEI,DLCT显著高于PEI;差异集中于<10mm病灶。

核心结论

  • VMI40keV图像质量高于PEI;DLCT联合VMI40keV对NETLM的检测敏感度优于PEI;Gd-EOB-DTPA增强MR对NETLM检测的诊断效能最佳。

研究设计与样本

  • 回顾性纳入72例疑似NETLM患者,均行DLCT和Gd-EOB-DTPA增强MR检查;参考标准为组织病理学、随访及所有可用影像的综合判读;两名放射科医师分别独立共识判读CT(含与不含VMI),另两名放射科医师共识判读MR。

关键影像表现/征象

  • VMI40keV的SNR和CNR在动脉期和静脉期均显著高于PEI(均P<0.01)。
  • 共识别477个病灶,其中转移瘤396个、良性病灶81个。

诊断标准与关键数值

  • 病灶水平AUC:PEI 0.86、DLCT 0.91、Gd-EOB-DTPA增强MR 0.97。
  • 敏感度:PEI 0.76、DLCT 0.86、Gd-EOB-DTPA增强MR 0.95;DLCT显著高于PEI,MR显著高于DLCT和PEI。
  • 亚组分析显示诊断效能差异集中于<10mm病灶。

临床应用与阅片要点

  • DLCT联合VMI40keV可提高NETLM检测敏感度,尤其对<10mm病灶的检出优于PEI。
  • Gd-EOB-DTPA增强MR对NETLM检测的诊断效能最佳。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To explore the optimal of kiloelectron voltage (keV) of virtual monoenergetic imaging (VMI) of dual-layer spectral-detector CT (DLCT) in detecting neuroendocrine tumor liver metastases (NETLM) and to investigate diagnostic performance of polyenergetic images (PEI), DLCT, and Gd-EOB-DTPA-enhanced MR.

METHODS: Seventy-two patients with suspected NETLM who underwent DLCT and Gd-EOB-DTPA-enhanced MR were retrospectively enrolled. Tumor signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were compared between PEI and VMI at 40-140 keV. Two radiologists read the CT examinations with and without VMI separately in consensus. Two other radiologists read the Gd-EOB-DTPA-enhanced MR in consensus. The diagnostic performance was evaluated. Reference standard was histopathology, follow-up, and interpretation of all available imaging.

RESULTS: The highest SNR and CNR were observed at VMI40keV, significantly higher than PEI in the arterial and venous phases (all P<0.01). A total of 477 lesions were identified (396 metastases, 81 benign lesions). Per-lesion AUC was 0.86, 0.91, and 0.97 (PEI, DLCT, and Gd-EOB-DTPA-enhanced MR, respectively). Sensitivity of PEI, DLCT, and Gd-EOB-DTPA-enhanced MRI were 0.76, 0.86, and 0.95, respectively. DLCT significantly improved sensitivity compared to PEI. MR had significantly higher sensitivity than DLCT and PEI. Subgroup analysis demonstrated that the difference in diagnostic performance was concentrated on lesions < 10 mm.

CONCLUSION: The image quality of VMI40keV is higher than that of PEI. DLCT with VMI40keV provides better diagnostic sensitivity for NETLM detection than PEI. Gd-EOB-DTPA-enhanced MR yielded the best diagnostic performance for NETLM detection.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Xie T, Liu W, Chen L, et al. Head-to-head comparison of contrast-enhanced CT, dual-layer spectral-detector CT, and Gd-EOB-DTPA-enhanced MR in detecting neuroendocrine tumor liver metastases. Eur J Radiol. 2024. PMID: 39241307. doi:10.1016/j.ejrad.2024.111710

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。